Imagen de Google Jackets

Heparin - A Century of Progress [electronic resource] / edited by Rebecca Lever, Barbara Mulloy, Clive P. Page.

Por: Colaborador(es): Tipo de material: TextoTextoSeries Handbook of Experimental Pharmacology ; 207 | Handbook of Experimental Pharmacology ; 207Editor: Berlin, Heidelberg : Springer Berlin Heidelberg, 2012Descripción: XIV, 462 p. online resourceTipo de contenido:
  • text
Tipo de medio:
  • computer
Tipo de soporte:
  • online resource
ISBN:
  • 9783642230561
Trabajos contenidos:
  • SpringerLink (Online service)
Tema(s): Formatos físicos adicionales: Sin títuloClasificación CDD:
  • 615 23
Clasificación LoC:
  • RM1-950
Recursos en línea:
Contenidos:
Springer eBooksResumen: Heparins remain amongst the most commonly used drugs in clinical practice. Almost 100 years have passed since the initial discovery of this complex substance and, during this time, understanding of the nature and uses of heparin and related molecules has grown dramatically. The aim of this volume is to summarise the developments that have led to the current status of both heparins as drugs and the field of heparin research, with a focus on the particularly rapid progress that has been made over the past three decades. Individual sections are dedicated to the nature of heparin as a biological molecule, the current approaches and techniques that are used to ensure the safety and reliability of heparin as a medicine, the clinical pharmacology of heparin as an anticoagulant drug, effects and potential applications of heparin aside of those involving haemostasis and, finally, the nature and potential uses of heparin-like materials from both natural and synthetic sources.
Etiquetas de esta biblioteca: No hay etiquetas de esta biblioteca para este título. Ingresar para agregar etiquetas.
Valoración
    Valoración media: 0.0 (0 votos)
No hay ítems correspondientes a este registro

Part 1. Introduction -- Part 2. Unfractionated and Low Molecular Weight Heparins -- Part 3. Clinical Use of Heparin and LMWH -- Part 4. Non Anticoagulant Indictions for Heparin and Related Compounds -- Part 5. Heparin-like Entities.

Heparins remain amongst the most commonly used drugs in clinical practice. Almost 100 years have passed since the initial discovery of this complex substance and, during this time, understanding of the nature and uses of heparin and related molecules has grown dramatically. The aim of this volume is to summarise the developments that have led to the current status of both heparins as drugs and the field of heparin research, with a focus on the particularly rapid progress that has been made over the past three decades. Individual sections are dedicated to the nature of heparin as a biological molecule, the current approaches and techniques that are used to ensure the safety and reliability of heparin as a medicine, the clinical pharmacology of heparin as an anticoagulant drug, effects and potential applications of heparin aside of those involving haemostasis and, finally, the nature and potential uses of heparin-like materials from both natural and synthetic sources.

ZDB-2-SBL

No hay comentarios en este titulo.

para colocar un comentario.